Newly Diagnosed Type 2 Diabetes
Showing 1 - 25 of >10,000
Type2diabetes Trial in Nasiriyah, Basrah (Insulin Glargine 100 UNT/ML Pen Injector [Lantus], Saxagliptin 2.5 mg/ Metformin
Not yet recruiting
- Type2diabetes
- Insulin Glargine 100 UNT/ML Pen Injector [Lantus]
- +2 more
-
Nasiriyah, Thi Qar, Iraq
- +1 more
Oct 28, 2023
Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)
Recruiting
- Insulin Pump,Continuous Glucose Monitoring Technology
- Insulin Glargine
- +3 more
-
Guandong, China刘烈华
Nov 7, 2023
The Alteration of Gut Microbiota and Analysis of Related Factors
Recruiting
- Type 2 Diabetes
-
Nanjing, Jiangsu, ChinaNanjing First hospital
Feb 21, 2023
Type 2 Diabetes Trial (GMRx4 polypill - sitagliptin, dapagliflozin, metformin, Metformin)
Not yet recruiting
- Type 2 Diabetes
- GMRx4 polypill - sitagliptin, dapagliflozin, metformin
- Metformin
- (no location specified)
Apr 27, 2023
Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg
Not yet recruiting
- Type2diabetes
- Insulin Resistance
- Metformin
- +2 more
- (no location specified)
Oct 20, 2022
Type2 Diabetes, Life Style Trial in Shanghai (intensive diet intervention, Enhanced physical activity intervention, Standard
Completed
- Type2 Diabetes
- Life Style
- intensive diet intervention
- +2 more
-
Shanghai, Shanghai, ChinaRuijin hospital, Shanghai Jiaotong University School of Medicine
Dec 22, 2022
Diabetes, Type 2 Trial in Hong Kong (Financial and social incentives, Financial incentives)
Recruiting
- Diabetes Mellitus, Type 2
- Financial and social incentives
- Financial incentives
-
Hong Kong, Hong KongSchool of Public Health, Li Ka Shing Faculty of Medicine, The Un
Nov 2, 2022
Glucotoxicity on Gastric Emptying in Chinese Newly Diagnosed
Active, not recruiting
- Type 2 Diabetes
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Mar 16, 2022
Type 2 Diabetes Trial in Antalya (Online Education, Control Group)
Completed
- Type 2 Diabetes
- Online Education
- Control Group
-
Antalya, TurkeyAkdeniz University
Apr 21, 2022
Treatment Adherence, Quality of Life, Glucose Metabolism Disorders (Including Diabetes) Trial in Estado De México (Intervention)
Recruiting
- Treatment Adherence
- +2 more
- Intervention
-
Estado De México, MexicoFacultad de Estudios Superiores Iztacala, Universidad Nacional A
Feb 12, 2023
Diabetes, Type 2 Trial in Hong Kong (Financial and social incentives)
Completed
- Diabetes Mellitus, Type 2
- Financial and social incentives
-
Hong Kong, Hong KongSchool of Public Health, Li Ka Shing Faculty of Medicine, The Un
May 17, 2022
Type 2 Diabetes Trial in Roma (flash glucose monitoring continuous, capillary blood test, flash glucose monitoring intermittent)
Recruiting
- Type 2 Diabetes
- flash glucose monitoring continuous
- +2 more
-
Roma, ItalyFondazione Policlinico Universitario Campus Bio-Medico
Oct 18, 2023
Diabetes, Type 2, Education, Mobile Applications Trial (Mobile Application Supported Nutrition and Diabetes Education)
Not yet recruiting
- Diabetes Mellitus, Type 2
- +3 more
- Mobile Application Supported Nutrition and Diabetes Education
- (no location specified)
Jan 27, 2022
Clinical Excellence in Newly Diagnosed Type 1 and Type 2
Not yet recruiting
- Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes
-
Seoul, Korea, Republic ofYonsei University Health System, Severance Hospital
May 29, 2022
Type 1 Diabetes Trial in Calgary (Prebiotic, Placebo)
Recruiting
- Type 1 Diabetes
- Prebiotic
- Placebo
-
Calgary, Alberta, CanadaUniversity of Calgary
Jun 30, 2022
Diabetes, Type 2 Trial (AURORA Care Strategy)
Not yet recruiting
- Diabetes Mellitus, Type 2
- AURORA Care Strategy
- (no location specified)
Feb 23, 2023
Newly Diagnosed Type 2 Diabetes Trial in Parma (Metformin-Sitagliptin-Empaglifozin-Pioglitazone, Standard of care)
Recruiting
- Newly Diagnosed Type 2 Diabetes
- Metformin-Sitagliptin-Empaglifozin-Pioglitazone
- Standard of care
-
Parma, ItalyAzienda Ospedaliero Universitaria di Parma
Aug 10, 2021
Type 1 Diabetes Trial in Vancouver (Frexalimab, Placebo, Insulin)
Recruiting
- Type 1 Diabetes Mellitus
- Frexalimab
- +2 more
-
Vancouver, British Columbia, CanadaInvestigational Site Number : 1240001
Oct 31, 2023
Endocrine Hormones to Hypoglycemia in Type 1 or Type 2 Diabetes
Completed
- Diabetes
- The hyperinsulinaemic hypoglycaemic clamp
-
Nanjing, ChinaNanjing First Hospital, Nanjing Medical Univesity
Oct 10, 2022
Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Abrocitinib 200 MG Oral Tablet
- +2 more
- (no location specified)
Feb 21, 2023
Diabetes, Type 2, Cancer Trial in Gainesville (Nurse-led diabetes care)
Terminated
- Diabetes Mellitus, Type 2
- Cancer
- Nurse-led diabetes care
-
Gainesville, FloridaUniversity of Florida
Mar 14, 2022
Diabetes, Type 2 Trial in Charlottesville (GEM + CGM)
Completed
- Diabetes Mellitus, Type 2
- GEM + CGM
-
Charlottesville, VirginiaDept. of Psychiatry and Neurobehavioral Sciences, University of
Oct 4, 2021
Learn More About How Acarbose and Metformin Work When Taken
Recruiting
- Type 2 Diabetes Mellitus
- BAY81-9783 (Acarbose/Metformin)
-
Multiple Locations, IndiaMany locations
Aug 10, 2022